Cancer Letters
Volume 206, Issue 2 , Pages 137-148, 8 April 2004

From Ras signalling to ChoK inhibitors: a further advance in anticancer drug design

Department of Molecular and Cellular Biology of Cancer, Instituto de Investigaciones Biomédicas, CSIC, Arturo Duperier 4, Madrid 28029, Spain

Received 21 July 2003; accepted 1 August 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(03)00633-5

doi:10.1016/j.canlet.2003.08.031

Cancer Letters
Volume 206, Issue 2 , Pages 137-148, 8 April 2004

Article Tools

* Image Usage & Resolution